Complications of bone metastases from malignant melanoma.

•We examined the frequency, morbidity and outcome of patients with BMs form MM.•Of 518 patients identified with metastatic MM, 17.2% (n = 89) developed BMs.•Of 89 patients with BM, 74.2% had multiple bone lesions.•66.3% of patients with BMs developed one or more skeletal related events.•Median survival from development of BMs is very short (17.3 weeks).